These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34510014)
1. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. DeDent AM; Farrand E Thorax; 2022 Jan; 77(1):9-10. PubMed ID: 34510014 [No Abstract] [Full Text] [Related]
2. COVID-19 vaccine-related interstitial lung disease: a case study. Park JY; Kim JH; Lee IJ; Kim HI; Park S; Hwang YI; Jang SH; Jung KS Thorax; 2022 Jan; 77(1):102-104. PubMed ID: 34362838 [No Abstract] [Full Text] [Related]
3. A case of severe interstitial lung disease after COVID-19 vaccination. Kono A; Yoshioka R; Hawk P; Iwashina K; Inoue D; Suzuki M; Narita C; Haruta K; Miyake A; Yoshida H; Tosaka N QJM; 2022 Jan; 114(11):805-806. PubMed ID: 34618126 [No Abstract] [Full Text] [Related]
5. Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination. Amiya S; Fujimoto J; Matsumoto K; Yamamoto M; Yamamoto Y; Yoneda M; Kuge T; Miyake K; Shiroyama T; Hirata H; Takeda Y; Kumanogoh A Int J Infect Dis; 2022 Mar; 116():255-257. PubMed ID: 35065256 [TBL] [Abstract][Full Text] [Related]
6. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection. Simon HU; Karaulov AV; Bachmann MF Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911 [TBL] [Abstract][Full Text] [Related]
7. Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease. Mackintosh JA; Lipman M; Lowe DM; Renzoni EA Lancet Respir Med; 2021 Sep; 9(9):947-949. PubMed ID: 34274035 [No Abstract] [Full Text] [Related]
8. Reaction to dermal filler following COVID-19 vaccination. Osmond A; Kenny B J Cosmet Dermatol; 2021 Dec; 20(12):3751-3752. PubMed ID: 34706150 [No Abstract] [Full Text] [Related]
9. COVID-19 vaccination and a severe pain in the neck. Kyriacou A; Ioakim S; Syed AA Eur J Intern Med; 2021 Dec; 94():95-96. PubMed ID: 34690055 [No Abstract] [Full Text] [Related]
10. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review. Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB Front Public Health; 2021; 9():778964. PubMed ID: 34888290 [No Abstract] [Full Text] [Related]
11. Anaphylaxis is a rare reaction in COVID-19 vaccination. Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336 [TBL] [Abstract][Full Text] [Related]
14. Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database. Deb A; Abdelmalek J; Iwuji K; Nugent K J Prim Care Community Health; 2021; 12():21501327211029230. PubMed ID: 34219532 [TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2. Savva D; Battineni G; Amenta F; Nittari G Int J Infect Dis; 2021 Dec; 113():233-235. PubMed ID: 34597761 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021. Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519 [TBL] [Abstract][Full Text] [Related]
19. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns. Zellweger RM; Wartel TA; Marks F; Song M; Kim JH Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605 [TBL] [Abstract][Full Text] [Related]
20. Immediate reactions after mRNA SARS-CoV-2 vaccination. Jeimy S; Wong T; Song C CMAJ; 2021 Dec; 193(48):E1842. PubMed ID: 34772737 [No Abstract] [Full Text] [Related] [Next] [New Search]